Back to Screener

HeartSciences Inc. Common Stock (HSCS)

Price$1.94
Value ScoreD
Growth ScoreF
Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-35.54%
Price vs S&P 500 (4W)0.52%
VGM Score20.78
Market Capitalization$6.18M

All Metrics

Book Value / Share (Quarterly)$0.83
P/TBV (Annual)1.06x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-32.90%
Cash Flow / Share (Quarterly)$-2.32
Price vs S&P 500 (YTD)-45.38%
Gross Margin (TTM)57.90%
Net Profit Margin (TTM)-74972.20%
EPS (TTM)$-5.01
10-Day Avg Trading Volume0.05M
EPS Excl Extra (TTM)$-5.01
Revenue Growth (5Y)-41.63%
EPS (Annual)$-9.34
ROI (Annual)-318.00%
Gross Margin (Annual)56.78%
Net Profit Margin (5Y Avg)-80463.65%
Cash / Share (Quarterly)$1.07
ROA (Last FY)-207.56%
Revenue Growth TTM (YoY)-41.02%
EBITD / Share (TTM)$-3.74
Operating Margin (TTM)-67680.74%
Cash Flow / Share (Annual)$-6.65
P/B Ratio2.33x
P/B Ratio (Quarterly)3.83x
Net Income / Employee (Annual)$-584,300
EV / Revenue (TTM)726.90x
Net Interest Coverage (TTM)-16.51x
ROA (TTM)-140.19%
EPS Incl Extra (Annual)$-9.34
Current Ratio (Annual)0.59x
Quick Ratio (Quarterly)1.00x
3-Month Avg Trading Volume0.02M
52-Week Price Return-45.96%
Revenue / Employee (TTM)$600
Tangible BV / Share (Quarterly)$0.17
P/S Ratio (Annual)1420.23x
Asset Turnover (Annual)0.00x
52-Week High$6.47
Operating Margin (5Y Avg)-76697.50%
EPS Excl Extra (Annual)$-9.34
CapEx CAGR (5Y)21.50%
26-Week Price Return-27.62%
Quick Ratio (Annual)0.39x
13-Week Price Return-28.90%
Total Debt / Equity (Annual)12.43x
Current Ratio (Quarterly)1.19x
Enterprise Value$6.30M
Revenue / Share Growth (5Y)-10.48%
Asset Turnover (TTM)0.00x
Revenue / Employee (Annual)$300
Inventory Turnover (Annual)0.00x
Pretax Margin (Annual)-201499.54%
Cash / Share (Annual)$0.98
3-Month Return Std Dev71.06%
Gross Margin (5Y Avg)54.72%
Net Income / Employee (TTM)$-565,700
ROE (Last FY)-4272.18%
Net Interest Coverage (Annual)-11.03x
EPS Basic Excl Extra (Annual)$-9.34
Receivables Turnover (TTM)2.48x
Total Debt / Equity (Quarterly)1.33x
EPS Incl Extra (TTM)$-5.01
Receivables Turnover (Annual)4.44x
ROI (TTM)-185.53%
P/S Ratio (TTM)712.57x
Pretax Margin (5Y Avg)-80463.65%
Revenue / Share (Annual)$0.00
Tangible BV / Share (Annual)$8.47
Price vs S&P 500 (52W)-70.33%
Year-to-Date Return-37.22%
5-Day Price Return-4.44%
EPS Normalized (Annual)$-9.34
ROA (5Y Avg)-165.73%
Net Profit Margin (Annual)-201499.54%
Month-to-Date Return16.16%
Cash Flow / Share (TTM)$-0.67
EBITD / Share (Annual)$-8.86
Operating Margin (Annual)-192013.10%
LT Debt / Equity (Annual)0.00x
LT Debt / Equity (Quarterly)0.16x
EPS Basic Excl Extra (TTM)$-5.01
P/TBV (Quarterly)18.91x
P/B Ratio (Annual)18.47x
Inventory Turnover (TTM)0.01x
Pretax Margin (TTM)-74972.20%
Book Value / Share (Annual)$0.18
Price vs S&P 500 (13W)-37.16%
Beta1.85x
Revenue / Share (TTM)$0.00
ROE (TTM)-333.38%
52-Week Low$1.63
vGradeD
gGradeF
mGradeD
vgmGradeD
Show chart for

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
4.13
4.13
4.13
4.13

Industry Peers — Orthopedic & Prosthetic Devices(33)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
HSCSHeartSciences Inc. Common Stock
DFD$1.94
ISRGIntuitive Surgical Inc.FBC$422.06
EWEdwards Lifesciences CorpDCC$85.96
STESTERIS plcCBC$212.35
ZBHZimmer Biomet Holdings, Inc.BCC$87.33
ALGNAlign Technology IncBCC$167.74
SNNSmith & Nephew plcBCC$30.61
MSAMine Safety IncorporatedBCC$161.30
ESTAEstablishment Labs Holdings Inc.FAB$74.31
ENOVEnovis CorporationBDC$23.78
CDRECadre Holdings, Inc.CCD$30.01

About

HeartSciences Inc develops artificial intelligence-powered ECG solutions for earlier detection of heart disease in clinical and point-of-care settings. The company's technology is delivered through MyoVista Insights, a cloud platform compatible with existing ECG devices, and MyoVista wavECG, a standalone device. By enhancing the diagnostic value of standard ECGs, HeartSciences addresses the significant need for improved cardiac screening in frontline healthcare environments.